Fierce Pharma
MARCH 13, 2024
As CDMO giants Wuxi AppTec and WuXi Biologics come under mounting scrutiny for their alleged ties to Chinese government officials, they are losing a key ally in Washington, D.C. | As CDMO giants Wuxi AppTec and WuXi Biologics come under mounting scrutiny for their alleged ties to Chinese government officials, they are losing a key ally in Washington, D.C.
MedCity News
MARCH 13, 2024
Placing research in the hands of a large pharmaceutical company is a goal of many biotech companies. IFM Therapeutics has now done it three times and its latest deal is the second time Novartis is the acquirer.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
MARCH 13, 2024
It didn’t take long for Johnson & Johnson CEO Joaquin Duato to catch up to his predecessor. | It didn’t take long for Johnson & Johnson CEO Joaquin Duato to catch up to his predecessor. After paying Duato $13.1 million in his first year as CEO, the pharma giant more than doubled his compensation to $28.4 million last year, according to a regulatory filing.
Eversana Intouch
MARCH 13, 2024
Our team is on the ground at SXSW 2024, and as we navigate through the bustling streets of downtown Austin, Texas — where the magic of immersive brand experiences dress the streets — we can’t help but feel the pulse of innovation surrounding us. In this blog, Hattie Stearns, Senior Director, Experience Design & Innovation, delves into several key trends and insights from Day 1 of the conference, including the importance of building authentic immersive experiences that enable human connection
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
MARCH 13, 2024
The FDA has raised concerns about early clinical trial deaths as part of two applications that aim to move the CAR-T therapies Carvykti and Abecma into earlier lines of treatment for multiple myelo | Ahead of an important advisory committee meeting, the FDA has raised concerns about early trial deaths for multiple myeloma cell therapies. At the meeting, experts will discuss applications that aim to move the CAR-T therapies Carvykti and Abecma into earlier lines of treatment.
pharmaphorum
MARCH 13, 2024
Amazon Pharmacy will provide dispensing for Eli Lilly’s recently launched direct-to-consumer LillyDirect channel, covering obesity, diabetes, and migraine drugs.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
European Pharmaceutical Review
MARCH 13, 2024
Findings from an experimental study report the development of a rapid method for the detection of pseudomonas aeruginosa bacteria in medications. The corresponding research paper stated the key benefits of the method include its high selectivity and specificity, cost-effectiveness as well as simplicity for application. For example, the author shared that the procedure can be used in microbiological laboratories of various levels.
Fierce Pharma
MARCH 13, 2024
After a few holdups, Swiss skincare company Galderma is finally going public in a highly anticipated market debut that could make for one of Europe’s largest listings this year. | The Swiss skincare company set its price range for a public offering after years of delays, with its listing now expected on March 22. The IPO could be one of Europe's largest this year.
European Pharmaceutical Review
MARCH 13, 2024
FDA inspections Identification of data integrity deviations Of the 70 Warning Letters issued by the US Food and Drug Administration (FDA) so far in 2024, three have identified data integrity issues at pharmaceutical manufacturing sites outside the US. Specifically, these recent warning letters describe microbiology and environmental monitoring related data integrity issues.
Fierce Pharma
MARCH 13, 2024
About a year after launching a prior round of layoffs, Coherus BioSciences is again reducing its head count, this time by 30%. | About a year after launching a prior round of layoffs, Coherus BioSciences is again reducing its head count, this time by 30%.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
European Pharmaceutical Review
MARCH 13, 2024
The first and only investigational targeted oral peptide has been shown to maintain high rates of skin clearance in adults with moderate-to-severe plaque psoriasis through 52 weeks, new data shows. In the long-term extension FRONTIER 2 study , JNJ-2113 demonstrated sustained efficacy from Week 16 to Week 52, based on data presented at the American Academy of Dermatology (AAD) 2024 Annual Meeting.
Fierce Pharma
MARCH 13, 2024
Merck is kicking its Keytruda-related clash with Johns Hopkins University (JHU) up a notch by asking the U.S. Patent and Trademark Office (PTO) to weigh in following a 2022 complaint. | The company in 2022 claimed the research university breached its contracts relating to a joint trial the two ran in 2013 and wrongly secured patents for itself from the study.
pharmaphorum
MARCH 13, 2024
Basecamp Research launches BaseFold, a deep learning model that it says surpasses benchmark tool AlphaFold2 and should accelerate AI-based drug discovery
Fierce Pharma
MARCH 13, 2024
FDA has OKed Mirum’s Livmarli to treat the rare liver disease PFIC.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
pharmaphorum
MARCH 13, 2024
Prilenia Therapeutics is planning to file its Huntington’s disease drug pridopidine in the EU shortly, after mixed results in a phase 3 trial.
MedCity News
MARCH 13, 2024
Amazon Pharmacy will now provide home delivery services for certain medications through LillyDirect, the companies announced Wednesday.
Pharmaceutical Technology
MARCH 13, 2024
Bright Green has announced plans to expand its controlled substances drug production facility in New Mexico, US with an investment of $250m.
MedCity News
MARCH 13, 2024
Between the environment and your healthcare organization’s balance sheet, waste is a big deal. These promising strategies can help solve that problem.
pharmaphorum
MARCH 13, 2024
Basecamp Research launches BaseFold, a deep learning model that it says surpasses benchmark tool AlphaFold2 and should accelerate AI-based drug discovery.
MedCity News
MARCH 13, 2024
Join MedCity News and nearly 300 healthcare investors, startups, and innovative-minded executives in Chicago at the Ritz Carlton on May 21-22. Space is limited. Secure your spot today to attend!
pharmaphorum
MARCH 13, 2024
FDA reviewers seem unconvinced by Geron's data on myelodysplastic syndrome therapy imetelstat ahead of FDA adcomm meeting.
MedCity News
MARCH 13, 2024
Quantum Health is now offering a navigation service for Medicare Advantage plans. The company has traditionally served employers.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Pharmaceutical Commerce
MARCH 13, 2024
Steven H. Collis, who currently holds the position, will transition to executive chair of the board.
MedCity News
MARCH 13, 2024
At HIMSS, Philips and AWS announced that they are expanding their collaboration with the goal of scaling digitized pathology slides in the cloud. The partners seek to help pathology labs better store and analyze vast volumes of data, as well as adopt more streamlined, cloud-based workflows to reduce clinician burnout.
PharmaTimes
MARCH 13, 2024
The progressive neurological disorder affects approximately 12,400 people in Scotland
Pharmaceutical Technology
MARCH 13, 2024
Belcesiran is an antisense rnai oligonucleotide commercialized by Novo Nordisk, with a leading Phase II program in Alpha-1 Antitrypsin Deficiency (A1AD).
PharmaTimes
MARCH 13, 2024
Around 200,000 people in the US are expected to be diagnosed with the skin cancer this year
Clarivate
MARCH 13, 2024
Clarivate Plc , a leading global provider of transformative intelligence, has been awarded a contract from the USPTO which will transform capabilities for US examiners working on Design Patent applications. Using DesignVision from Clarivate, an Intellectual Property AI & Image Search Platform for Government, examiners will be able to easily expedite patent examinations by using reverse image search AI to quickly identify relevant prior art.
Pharmaceutical Commerce
MARCH 13, 2024
The Asia-Pacific location is expected to provide serialization solutions for counterfeit medication entering the pharma supply chain.
PharmaVoice
MARCH 13, 2024
Biotech IPOs are off to the races in 2024, and investors are betting on horses that are derisked in targeted areas.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
310 
Let's personalize your content